Litcius/Paper detail

The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial

Hertzel C. Gerstein, Robert G. Hart, Helen M. Colhoun, Rafael Díaz, Mark Lakshmanan, Fady T. Botros, Jeffrey L. Probstfield, Matthew C. Riddle, Lars Rydén, Charles Atisso, Leanne Dyal, Stephanie Hall, Álvaro Avezum, Jan Basile, Ignacio Conget, William C. Cushman, Nicolae Hâncu, M Hanefeld, Petr Janský, Mátyás Keltai, Fernando Laņas, Lawrence A. Leiter, Patricio López‐Jaramillo, Ernesto Muñoz, Nana Pogosova, Peter Raubenheimer, Jonathan E. Shaw, Wayne Huey‐Herng Sheu, Theodora Temelkova‐Kurktschiev

2020The Lancet Diabetes & Endocrinology145 citationsDOI

Topics & Concepts

DulaglutideMedicinePlaceboStroke (engine)Modified Rankin ScaleRandomized controlled trialInternal medicineDiabetes mellitusClinical trialType 2 diabetesPhysical therapyExenatideIschemic strokeEndocrinologyAlternative medicinePathologyEngineeringIschemiaMechanical engineeringDiabetes Treatment and ManagementMedication Adherence and ComplianceAntiplatelet Therapy and Cardiovascular Diseases